We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

60 hedge funds and large institutions have $489M invested in Beam Therapeutics in 2020 Q1 according to their latest regulatory filings, with 60 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

54.68% more ownership

Funds ownership: 0% → 54.68% (+55%)

Holders
60
Holders Change
+60
Holders Change %
–
% of All Funds
1.32%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
60
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$152M
2
RG
Redmile Group
California
+$73M
3
Temasek Holdings
Temasek Holdings
Singapore
+$72.9M
4
HA
HHLR Advisors
Cayman Islands
+$64.5M
5
Fidelity International
Fidelity International
Bermuda
+$35.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$125M +$152M +6,971,912 New
RG
2
Redmile Group
California
$60.5M +$73M +3,359,258 New
Temasek Holdings
3
Temasek Holdings
Singapore
$60.4M +$72.9M +3,354,641 New
HA
4
HHLR Advisors
Cayman Islands
$53.4M +$64.5M +2,966,403 New
Fidelity International
5
Fidelity International
Bermuda
$29.3M +$35.4M +1,626,779 New
BlackRock
6
BlackRock
New York
$22.6M +$27.3M +1,254,005 New
HH
7
HSG Holding
Hong Kong
$20.2M +$24.4M +1,120,535 New
CAM
8
Cormorant Asset Management
Massachusetts
$14.3M +$17.3M +796,429 New
AI
9
Alphabet Inc
California
$11.9M +$14.4M +663,691 New
Victory Capital Management
10
Victory Capital Management
Texas
$9.54M +$11.5M +529,742 New
Alkeon Capital Management
11
Alkeon Capital Management
New York
$9M +$10.9M +500,000 New
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$8.22M +$9.92M +456,447 New
Goldman Sachs
13
Goldman Sachs
New York
$6.53M +$7.89M +362,958 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$5.98M +$7.22M +332,000 New
OFM
15
Omega Fund Management
Massachusetts
$5.45M +$6.58M +302,821 New
Franklin Resources
16
Franklin Resources
California
$5.41M +$6.53M +300,509 New
SFM
17
Sphera Funds Management
Israel
$4.76M +$5.75M +264,681 New
MWNA
18
Marshall Wace North America
New York
$4.53M +$5.47M +251,762 New
Millennium Management
19
Millennium Management
New York
$3.84M +$4.63M +213,105 New
State Street
20
State Street
Massachusetts
$3.41M +$4.12M +189,381 New
FCM
21
Farallon Capital Management
California
$3.06M +$3.7M +170,164 New
Northern Trust
22
Northern Trust
Illinois
$2.36M +$2.85M +131,026 New
OAM
23
Oxford Asset Management
United Kingdom
$2.2M +$2.65M +122,123 New
GIM
24
Granahan Investment Management
Massachusetts
$1.77M +$2.14M +98,276 New
Vanguard Group
25
Vanguard Group
Pennsylvania
$1.69M +$2.04M +93,942 New
1
2 3

BEAM Hedge Fund Activity: Q1 2020 in Review

60 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q1 2020, worth a combined $489M.

Buyers outnumbered sellers: 60 funds opened new BEAM positions and 0 closed out — a net gain of 60 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $152M.

  • 60 institutional investors held Beam Therapeutics (BEAM) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $489M of Beam Therapeutics stock for Q1 2020.
  • 60 funds opened new Beam Therapeutics positions in Q1 2020 and 0 closed out, a net change of +60 holders.
  • The largest Beam Therapeutics buyer in Q1 2020 was Fidelity Investments, an estimated $152M added.

Based on aggregated 13F filings for Q1 2020.